Unknown

Dataset Information

0

Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals.


ABSTRACT: Neuroinflammation and traumatic brain injury involve activation of inflammatory cells and production of local pro-inflammatory mediators that can amplify tissue damage. Using LC-UV-MS-MS-based lipidomics in tandem with functional screening at the single-cell level in microfluidic chambers, we identified a series of novel bioactive oxygenated docosahexaenoyl ethanolamide- (DHEA) derived products that regulated leukocyte motility. These included 10,17-dihydroxydocosahexaenoyl ethanolamide (10,17-diHDHEA) and 15-hydroxy-16(17)-epoxy-docosapentaenoyl ethanolamide (15-HEDPEA), each of which was an agonist of recombinant CB2 receptors with EC(50) 3.9 × 10(-10) and 1.0 × 10(-10) M. In human whole blood, 10,17-diHDHEA and 15-HEDPEA at concentrations as low as 10 pM each prevented formation of platelet-leukocyte aggregates involving either platelet-monocyte or platelet-polymorphonuclear leukocyte. In vivo, 15-HEDPEA was organ-protective in mouse reperfusion second organ injury. Together these results indicate that DHEA oxidative metabolism produces potent novel molecules with anti-inflammatory and organ-protective properties.

SUBMITTER: Yang R 

PROVIDER: S-EPMC3173121 | biostudies-literature | 2011 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals.

Yang Rong R   Fredman Gabrielle G   Krishnamoorthy Sriram S   Agrawal Nitin N   Irimia Daniel D   Piomelli Daniele D   Serhan Charles N CN  

The Journal of biological chemistry 20110712 36


Neuroinflammation and traumatic brain injury involve activation of inflammatory cells and production of local pro-inflammatory mediators that can amplify tissue damage. Using LC-UV-MS-MS-based lipidomics in tandem with functional screening at the single-cell level in microfluidic chambers, we identified a series of novel bioactive oxygenated docosahexaenoyl ethanolamide- (DHEA) derived products that regulated leukocyte motility. These included 10,17-dihydroxydocosahexaenoyl ethanolamide (10,17-d  ...[more]

Similar Datasets

| S-EPMC3968752 | biostudies-literature
| S-EPMC6838076 | biostudies-literature
2021-02-27 | GSE160086 | GEO
| S-EPMC5553866 | biostudies-other
| S-EPMC2999475 | biostudies-literature
| S-EPMC3922980 | biostudies-literature
| S-EPMC6609925 | biostudies-literature
| S-EPMC3664231 | biostudies-literature
| S-EPMC5535759 | biostudies-literature
| S-EPMC4076262 | biostudies-literature